Aktis Oncology, Inc. (AKTS)

Aktis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	37.78	37.16	29.51	128.6
Short-Term Investments	189	260.01	68.35	-
Cash & Short-Term Investments	226.79	297.17	97.86	128.6
Cash Growth	-23.68%	203.66%	-23.90%	-
Other Receivables	-	1.1	0.3	-
Receivables	-	1.1	0.3	-
Prepaid Expenses	3.52	2.59	2.04	3.88
Total Current Assets	230.31	300.85	100.2	132.48
Property, Plant & Equipment	27.25	20.87	20.92	4.87
Other Long-Term Assets	7.33	4.46	1.23	0.98
Total Assets	264.89	326.18	122.36	138.32
Accounts Payable	1.74	1.92	0.96	0.49
Accrued Expenses	9.52	6.33	3.75	3.93
Current Portion of Leases	1.32	1.3	1.53	0.85
Current Unearned Revenue	18.66	9.28	-	-
Total Current Liabilities	31.24	18.82	6.24	5.28
Long-Term Leases	10.23	10.71	11.87	0.92
Long-Term Unearned Revenue	36.16	51.04	-	-
Other Long-Term Liabilities	-	-	0.5	1.31
Total Liabilities	77.63	80.58	18.61	7.5
Additional Paid-In Capital	10.37	4.91	2.47	0.98
Retained Earnings	-156.56	-92.83	-48.85	-20.21
Comprehensive Income & Other	0.04	0.12	0.08	-
Total Common Equity	-146.15	-87.8	-46.31	-19.23
Shareholders' Equity	187.26	245.61	103.74	130.82
Total Liabilities & Equity	264.89	326.18	122.36	138.32
Total Debt	11.55	12.01	13.4	1.78
Net Cash (Debt)	215.24	285.16	84.46	126.82
Net Cash Growth	-24.52%	237.63%	-33.40%	-
Net Cash Per Share	-	404.96	137.29	245.11
Filing Date Shares Outstanding	-	0.78	0.65	0.52
Total Common Shares Outstanding	-	0.78	0.65	0.52
Working Capital	199.07	282.03	93.97	127.21
Book Value Per Share	-	-112.42	-71.27	-37.17
Tangible Book Value	-146.15	-87.8	-46.31	-19.23
Tangible Book Value Per Share	-	-112.42	-71.27	-37.17
Machinery	-	8.81	6.4	2.74
Construction In Progress	-	1.33	0.4	0.56
Leasehold Improvements	-	0.17	0.17	0.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q